NAPIGEN, INC.

📍 Wilmington, United States🗓 Founded 2016👥 19 employees💰 Last funded Apr 2016
Biotechnology Research🌐 napigen.com
Website LinkedIn
NAPIGEN is a biotechnology company that addresses novel genome engineering of various organisms such as plants, microbes and animals. Our technology targets two special cellular components known as organelles that harbor their own DNA. Those organelles are called mitochondria and chloroplasts. Both organelles are important to create energy for cells to grow. They are also critical for producing various biochemical molecules key to specific pathways and functions. Our genome technology has broad application areas. They range from industrial biotechnology to animal and human healthcare as well as to agriculture. Our mission is to harness the potentials of organelles to make our society a better place to live.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2016
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in NAPIGEN, INC.?
NAPIGEN, INC. has 1 investors on record on gritt.io, including 1 early-stage backers.
When did NAPIGEN, INC. last raise funding?
The most recent investment in NAPIGEN, INC. recorded on gritt.io was in April 2016.
When was NAPIGEN, INC. founded?
NAPIGEN, INC. was founded in 2016.
What industry is NAPIGEN, INC. in?
NAPIGEN, INC. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is NAPIGEN, INC. based?
NAPIGEN, INC. is headquartered in Wilmington, United States.